Immuno Oncology Assays | An Emerging Market Growing at a CAGR of 12.7%
The global immuno oncology assays market to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The rising incidence of cancer and increasing adoption of targeted therapy are the key factors driving …